Abdul Jabbar Omar Alsaleh

Tesi di Laurea Magistrale

• Cost-effectiveness analysis of ofatumumab as a second line high-efficacy therapy for relapsing-remitting multiple sclerosis in Italy
• Cost-effectiveness analysis of Onasemnogene Abeparvovec-xioi (Zolgensma®) and best supportive care treatment for Spinal Muscular Atrophy I in the Netherlands with early-treatment scenario
• Economic evaluation on the use of silicone versus hydrocolloid dressings in stoma care related to leakage and mechanical trauma prevention to peristomal skin
• The new European regulation on HTA: the pharmaceutical perspective of Roche